Abstract:In this study, the characteristics of hemodynamic changes with use of toremifene before and after neoadjuvant chemotherapy in breast cancer treatment were analyzed using resting-state functional magnetic resonance imaging. Also, the effect of toremifene on the quality of life of patients with advanced breast cancer was analyzed. The study population comprised 100 patients who received endocrine therapy after breast cancer surgery in our hospital from January 2016 to January 2019. Patients were randomly divided into an observation group and a control group, with 50 cases in each group. The observation group was treated with tamoxifen combined with toremifene treatment; the control group was treated with toremifene. Before and after chemotherapy, the same scheme was used to perform dynamic contrast-enhanced imaging of the breast using a 1.5T superconducting scanner with 3 mL/second bolus injection of adiphenine meglumine 0.2 mmol/kg. Semiquantitative blood flow measurement was completed on the workstation and before and after chemotherapy to compare results. The patient's quality of life, progesterone and estrogen levels, social function, physical function, mental function, and material function were analyzed. The mean values of the early enhancement parameters Efirst, Vfirst, Ee, and Ve before chemotherapy were greater than in the residual lesions after chemotherapy (P < 0.5). The semiquantitative study of resting brain function before and after breast cancer neoadjuvant chemotherapy showed that the hemodynamics of the residual lesions were significantly reduced, and the blood flow rate was significantly reduced. Compared with the clinical effect of tamoxifen in the treatment of breast cancer after surgery, tamoxifen combined with toremifene has more advantages in improving quality of life, improving progesterone levels, and reducing estrogen levels, and it has no detrimental effects on the endometrium.

The adverse effect of anticancer drug toremifene on vascular smooth muscle cells is an important aspect of its tumor growth inhibition

Effect of transcatheter arterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor in cervical squamous cell carcinoma

Mitogen-activated Protein Kinase Pathway in Antitumor Effect of Toremifene

Effect of Toremifene on Endometrium and Neurocognitive Function in Patients with Breast Cancer Based on Resting-State Functional Magnetic Resonance Imaging

Effect of Tetrandrine and Toremifene on the Reversion of Multidrug Resistance of K562/A02 Cell Line

The Effects of Methotrexate on Vascular Smooth Muscle Cells Proliferation, Migration and Apoptosis

Thrombosis of acute superior mesenteric artery in a patient with breast cancer receiving toremifene therapy: a case report and literature review

[The in vitro combination-effect of toremifene with CAF (cyclophosphamide, adriamycin, 5-fluorouracil) on growth of various human mammary carcinomas].

[Effect of Extract from Tripterygium Hypoglaucum on Proliferation and Apoptosis of Vascular Smooth Muscle Cells].

Effect of Proliferation and Cell Cycle of Febrifugal and Antipyic Drugs on Vascular Smooth Muscle Cells

Comparison of effects of tamoxifen and Toremifene on hepatic function and serum lipids in breast cancer patients during adjuvant endocrine therapy

[Inhibitory Effect of Tetrandrine on Angiogenesis].

Reversal effect of toremifene and tamoxifen on multidrug resistance in MCF7/ADR cell

Unraveling the Action Mechanism of Tubeimoside-1 against Tumor Microvessels via Network Pharmacology and Experimental Validation

Effect of Triptolide on Proliferation of Rat Vascular Smooth Muscle Cells

Effect of proliferation and cell cycle of febrifugal and antipyric drugs on vascular smooth muscle cells

Role of estrogen receptor/progesterone receptor in toremifene-induced reversal of multidrug resistance in MCF7/ADR cells

Effects of Tripterine on Mrna Expression of Oncogene C-Myc and Platelet-Derived Growth Factor of Vascular Smooth Muscle Cells in Rats

Endocrine Vasculatures Are Preferable Targets of an Antitumor Ineffective Low Dose of Anti-Vegf Therapy.

Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer

Effect of Soluble Vascular Endothelial Growth Factor( VEGF) Receptor Gene (sflt- 1) and Antisense VEGF Nucleotide on Neovascularization